Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEP-701 in Advanced Multiple Myeloma
NCT00242827Phase 2Terminated
- Sponsor
- Cephalon, Inc.
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lestaurtinib in multiple myeloma (MM), sponsored by Cephalon, Inc. Started Apr 2006; status: terminated.
02
Drugs
lestaurtinib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00242827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00242827.